{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:41:20Z","timestamp":1791589280627,"version":"4.3.4"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM133483"],"award-info":[{"award-number":["R35GM133483"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["R21EB033595"],"award-info":[{"award-number":["R21EB033595"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007259","name":"Stony Brook University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL168093"],"award-info":[{"award-number":["R01HL168093"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W911QY2220006"],"award-info":[{"award-number":["W911QY2220006"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Biotechnology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.tibtech.2026.07.015","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:27:54Z","timestamp":1786998474000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["On-target and off-target activities of CRISPR therapeutics across scales"],"prefix":"10.1016","author":[{"given":"Merna","family":"Magdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin R.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abishek","family":"Dhungana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Herring-Nicholas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee N.","family":"Cottle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5330-6842","authenticated-orcid":false,"given":"Eric A.","family":"Josephs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tibtech.2026.07.015_bb0005","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMc2313119","article-title":"Specificity of CRISPR-Cas9 editing in exagamglogene autotemcel","volume":"390","author":"Yen","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0010","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJMoa2309676","article-title":"Exagamglogene autotemcel for severe sickle cell disease","volume":"390","author":"Frangoul","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0015","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa2504747","article-title":"Patient-specific in vivo gene editing to treat a rare genetic disease","volume":"392","author":"Musunuru","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0020","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1056\/NEJMsb2512695","article-title":"FDA\u2019s new plausible mechanism pathway","volume":"393","author":"Prasad","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0025","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41467-020-20633-y","article-title":"CRISPR technologies and the search for the PAM-free nuclease","volume":"12","author":"Collias","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0030","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1038\/s41467-024-47830-3","article-title":"Unraveling the mechanisms of PAMless DNA interrogation by SpRY-Cas9","volume":"15","author":"Hibshman","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0035","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41587-022-01492-y","article-title":"Precise DNA cleavage using CRISPR-SpRYgests","volume":"41","author":"Christie","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0040","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.1038\/s41467-023-41829-y","article-title":"PAM-flexible genome editing with an engineered chimeric Cas9","volume":"14","author":"Zhao","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0045","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.molcel.2026.03.030","article-title":"Rapid customization of base editors via machine learning-powered combinatorial mutagenesis","volume":"86","author":"Peng","year":"2026","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0050","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41586-024-07497-8","article-title":"Structural basis for pegRNA-guided reverse transcription by a prime editor","volume":"631","author":"Shuto","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s43586-026-00478-3","article-title":"Precision genome editing with DNA base editors","volume":"6","author":"Mawson","year":"2026","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0060","article-title":"Probabilistic modelling of prime editing variant correction efficiency","author":"\u00d6zden","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0065","article-title":"Balancing off-target and on-target considerations for optimized CRISPR-Cas9 knockout library design","volume":"6","author":"Drepanos","year":"2025","journal-title":"Technology"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0070","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/s41587-023-01678-y","article-title":"Prediction of prime editing insertion efficiencies using sequence features and DNA repair determinants","volume":"41","author":"Koeppel","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0075","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.cell.2023.03.034","article-title":"Prediction of efficiencies for diverse prime editing systems in multiple cell types","volume":"186","author":"Yu","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0080","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41587-023-01792-x","article-title":"Deep learning models to predict the editing efficiencies and outcomes of diverse base editors","volume":"42","author":"Kim","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13059-025-03488-8","article-title":"Genome-wide CRISPR guide RNA design and specificity analysis with GuideScan2","volume":"26","author":"Schmidt","year":"2025","journal-title":"Genome Biol."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0090","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMe2505721","article-title":"Personalized gene editing to treat an inborn error of metabolism","volume":"392","author":"Gropman","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0095","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa2309673","article-title":"Exagamglogene autotemcel for transfusion-dependent \u03b2-thalassemia","volume":"390","author":"Locatelli","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41588-025-02428-3","article-title":"Measurement and clinical interpretation of CRISPR off-targets","volume":"58","author":"Angelini Stewart","year":"2026","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0105","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41586-024-07087-8","article-title":"Durable and efficient gene silencing in vivo by hit-and-run epigenome editing","volume":"627","author":"Cappelluti","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0110","article-title":"An RNA-mediated DNA melting mechanism for CRISPR-Cas9","author":"Hedger","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0115","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.molcel.2025.03.024","article-title":"Rapid two-step target capture ensures efficient CRISPR-Cas9-guided genome editing","volume":"85","author":"Shi","year":"2025","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0120","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41551-025-01464-y","article-title":"GenomePAM directs PAM characterization and engineering of CRISPR-Cas nucleases using mammalian genome repeats","volume":"10","author":"Yu","year":"2026","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-025-02995-0","article-title":"Customizing CRISPR-Cas PAM specificity with protein language models","author":"Nayfach","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0130","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41586-025-09021-y","article-title":"Custom CRISPR-Cas9 PAM variants via scalable engineering and machine learning","volume":"643","author":"Silverstein","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0135","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41586-022-04470-1","article-title":"Structural basis for mismatch surveillance by CRISPR-Cas9","volume":"603","author":"Bravo","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0140","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1016\/j.cell.2022.09.026","article-title":"Structural basis for Cas9 off-target activity","volume":"185","author":"Pacesa","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0145","article-title":"Population-scale cellular GUIDE-seq-2 and biochemical CHANGE-seq-R profiles reveal human genetic variation frequently affects Cas9 off-target activity","author":"Lazzarotto","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0150","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41586-025-09537-3","article-title":"Engineered prime editors with minimal genomic errors","volume":"646","author":"Chauhan","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105333","article-title":"Polyvalent guide RNAs for CRISPR antivirals","volume":"25","author":"Bagchi","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0160","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkae759","article-title":"Learning to quantify uncertainty in off-target activity for CRISPR guide RNAs","volume":"52","author":"\u00d6zden","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0165","article-title":"Target-matched increased fidelity SpCas9 variants can edit any target without genome-wide off-target effects","author":"Kulcs\u00e1r","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0170","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41594-026-01753-3","article-title":"Improving the efficiency of high-fidelity Cas9 by enhancing PAM-distal interactions","volume":"33","author":"Zheng","year":"2026","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0175","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/s41551-025-01499-1","article-title":"Treatment of a severe vascular disease using a bespoke CRISPR-Cas9 base editor in mice","volume":"11","author":"Alves","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0180","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41551-023-01132-z","article-title":"Optimization of base editors for the functional correction of SMN2 as a treatment for spinal muscular atrophy","volume":"8","author":"Alves","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41573-024-01086-0","article-title":"Chemical engineering of CRISPR-Cas systems for therapeutic application","volume":"24","author":"Barber","year":"2025","journal-title":"Nat. Rev. Drug Discover"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0190","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s42003-024-05776-8","article-title":"Selection of extended CRISPR RNAs with enhanced targeting and specificity","volume":"7","author":"Herring-Nicholas","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0195","article-title":"TOP-SECRETS enables Cas9 nucleases to discriminate SNVs outside of PAMs","author":"Herring-Nicholas","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0200","article-title":"Balancing off-target and on-target considerations for optimized CRISPR-Cas9 knockout library design","volume":"6","author":"Drepanos","year":"2026","journal-title":"Cell Genom."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0205","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/s43588-023-00569-1","article-title":"Interpretable neural architecture search and transfer learning for understanding CRISPR\u2013Cas9 off-target enzymatic reactions","volume":"3","author":"Zhang","year":"2023","journal-title":"Nat. Comput. Sci."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0210","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41551-025-01463-z","article-title":"CRISPR-GPT for agentic automation of gene-editing experiments","volume":"10","author":"Qu","year":"2026","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0215","doi-asserted-by":"crossref","first-page":"W29","DOI":"10.1093\/nar\/gkae419","article-title":"AlPaCas: allele-specific CRISPR gene editing through a protospacer-adjacent-motif (PAM) approach","volume":"52","author":"Rosignoli","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0220","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41586-025-09507-9","article-title":"Systematic discovery of CRISPR-boosted CAR T cell immunotherapies","volume":"646","author":"Datlinger","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0225","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41587-025-02641-9","article-title":"QBEmax is a sequence-permuted and internally protected base editor","volume":"44","author":"Hu","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0230","doi-asserted-by":"crossref","first-page":"8115","DOI":"10.1038\/s41467-025-63609-6","article-title":"A streamlined base editor engineering strategy to reduce bystander editing","volume":"16","author":"Valdez","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0235","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-026-03045-z","article-title":"Precise, minimally evolved adenine base editors generated through mutation reversion analysis","author":"Evanoff","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0240","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1016\/j.cell.2025.06.038","article-title":"In vivo prime editing rescues alternating hemiplegia of childhood in mice","volume":"188","author":"Sousa","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0245","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2300605120","article-title":"Altered DNA repair pathway engagement by engineered CRISPR-Cas9 nucleases","volume":"120","author":"Chauhan","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0250","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41587-024-02307-y","article-title":"Tracking-seq reveals the heterogeneity of off-target effects in CRISPR-Cas9-mediated genome editing","volume":"43","author":"Zhu","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0255","doi-asserted-by":"crossref","first-page":"9883","DOI":"10.1038\/s41467-025-66058-3","article-title":"Characterizing and controlling CRISPR repair outcomes in nondividing human cells","volume":"16","author":"Ramadoss","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0260","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41551-025-01535-0","article-title":"High-throughput evaluation of in vitro CRISPR activities enables optimized large-scale multiplex enrichment of rare variants","volume":"10","author":"Yeo","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0265","article-title":"Rational design of synthetic proteins using a genome-scale CRISPR screen","author":"Burrell","year":"2026","journal-title":"bioRxiv"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0270","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1186\/s12864-022-09012-7","article-title":"Comprehensive computational analysis of epigenetic descriptors affecting CRISPR-Cas9 off-target activity","volume":"23","author":"Mak","year":"2022","journal-title":"BMC Genomics"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0275","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/s41588-025-02172-8","article-title":"Base editing of trinucleotide repeats that cause Huntington\u2019s disease and Friedreich\u2019s ataxia reduces somatic repeat expansions in patient cells and in mice","volume":"57","author":"Matuszek","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0280","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2515267122","article-title":"Precise gene editing of pathogenic Lamin A mutations corrects cardiac disease","volume":"122","author":"Caravia","year":"2025","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0285","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/s41586-025-09489-8","article-title":"In vivo CRISPR screens identify modifiers of CAR T cell function in myeloma","volume":"646","author":"Knudsen","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0290","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41577-025-01174-1","article-title":"In vivo CAR engineering for immunotherapy","volume":"25","author":"Li","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0295","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1016\/j.ymthe.2024.07.015","article-title":"Safety and efficacy studies of CRISPR-Cas9 treatment of sickle cell disease highlights disease-specific responses","volume":"32","author":"Frati","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0300","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41568-024-00768-6","article-title":"Genetic and epigenetic bases of long-term adverse effects of childhood cancer therapy","volume":"25","author":"Wang","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0305","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/s41588-025-02234-x","article-title":"The long-term effects of chemotherapy on normal blood cells","volume":"57","author":"Mitchell","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0310","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41576-025-00916-0","article-title":"Monitoring biological effects of somatic cell genome editing","volume":"27","author":"Freedman","year":"2026","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0315","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41588-022-01257-y","article-title":"Human genetic diversity alters off-target outcomes of therapeutic gene editing","volume":"55","author":"Cancellieri","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0320","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1056\/NEJMc2503294","article-title":"Specificity of CRISPR-Cas9 editing in exagamglogene autotemcel - update","volume":"393","author":"Yen","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0325","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1089\/crispr.2024.0082","article-title":"Give Cas a chance: an actionable path to a platform for CRISPR cures","volume":"7","author":"Urnov","year":"2024","journal-title":"CRISPR J."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0330","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41586-024-07800-7","article-title":"A roadmap for affordable genetic medicines","volume":"634","author":"Kliegman","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0335","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41586-025-09298-z","article-title":"Design of highly functional genome editors by modelling CRISPR-Cas sequences","volume":"645","author":"Ruffolo","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0340","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(23)02268-7","article-title":"Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study","volume":"403","author":"Weber","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0370","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1016\/j.cell.2024.07.023","article-title":"Safe and effective in vivo delivery of DNA and RNA using proteolipid vehicles","volume":"187","author":"Brown","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0375","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1038\/s41596-025-01154-8","article-title":"Peptide-enabled ribonucleoprotein delivery for CRISPR engineering (PERC) in primary human immune cells and hematopoietic stem cells","volume":"20","author":"Sahu","year":"2025","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0380","article-title":"Efficient in vivo mammalian neuron editing using peptide-mediated CRISPR enzyme delivery","author":"Manohar","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0385","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41551-023-01032-2","article-title":"Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes","volume":"7","author":"Foss","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0390","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.cell.2022.03.045","article-title":"Therapeutic in vivo delivery of gene editing agents","volume":"185","author":"Raguram","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.tibtech.2026.07.015_bb0395","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1016\/j.ymthe.2024.09.032","article-title":"AAV vector-derived elements integrate into Cas9-generated double-strand breaks and disrupt gene transcription","volume":"32","author":"Bazick","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0400","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0405","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41591-025-03508-x","article-title":"A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levels","volume":"31","author":"Tremblay","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.tibtech.2026.07.015_bb0410","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.122.062132","article-title":"Efficacy and safety of an investigational single-course CRISPR base-editing therapy targeting PCSK9 in nonhuman primate and mouse models","volume":"147","author":"Lee","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.tibtech.2026.07.015_bb3000","series-title":"The hedgehog and the fox: An essay on Tolstoy's view of history","author":"Berlin","year":"2013"},{"key":"10.1016\/j.tibtech.2026.07.015_bb2005","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-025-02948-7","article-title":"Sensitive and unbiased genome-wide profiling of base-editor-induced off-target activity using CHANGE-seq-BE","author":"Lazzarotto","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.07.015_bb2010","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1038\/s41467-024-51056-8","article-title":"Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy","volume":"15","author":"Bai","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2026.07.015_bb2015","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.actbio.2024.03.031","article-title":"Immunometabolic reprogramming of macrophages with inhalable CRISPR\/Cas9 nanotherapeutics for acute lung injury intervention","volume":"181","author":"Huang","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.tibtech.2026.07.015_bb2020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","article-title":"Identification of preexisting adaptive immunity to Cas9 proteins in humans","volume":"25","author":"Charlesworth","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.tibtech.2026.07.015_bb2025","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/s41551-019-0431-2","article-title":"Immune-orthogonal orthologues of AAV capsids and of Cas9 circumvent the immune response to the administration of gene therapy","volume":"3","author":"Moreno","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.tibtech.2026.07.015_bb2030","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ymthe.2020.04.017","article-title":"AAV-CRISPR gene editing is negated by pre-existing immunity to Cas9","volume":"28","author":"Li","year":"2020","journal-title":"Mol. Ther."}],"container-title":["Trends in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779926002945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779926002945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T03:46:45Z","timestamp":1787370405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167779926002945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":84,"alternative-id":["S0167779926002945"],"URL":"https:\/\/doi.org\/10.1016\/j.tibtech.2026.07.015","relation":{},"ISSN":["0167-7799"],"issn-type":[{"value":"0167-7799","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"On-target and off-target activities of CRISPR therapeutics across scales","name":"articletitle","label":"Article Title"},{"value":"Trends in Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tibtech.2026.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}